Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | NOS3 | P29474 | 5/20 | 0.34 |
| ▸ | NOS1 | P29475 | 5/20 | 0.34 |
| ▸ | NOS2 | P35228 | 5/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12386543 | 0.73 | — | — | |
| Butane SCHEMBL27896739 | 0.72 | TSHR (0.50) | CYP2D6TSHRCA1CA9KMT2A | |
| SCHEMBL6699276 | 0.69 | TSHR (0.39) | TSHR | |
| SCHEMBL6704133 | 0.69 | TSHR (0.39) | TSHR | |
| SCHEMBL5492137 | 0.68 | TSHR (0.67) | TSHRCA1CA9KMT2A | |
| SCHEMBL4197788 | 0.68 | TSHR (0.67) | TSHRCA1CA9KMT2A | |
| SCHEMBL5324654 | 0.68 | TSHR (0.67) | TSHRCA1CA9KMT2A | |
| SCHEMBL1014174 | 0.68 | TSHR (0.67) | TSHRCA1CA9KMT2A | |
| SCHEMBL180355 | 0.68 | TSHR (0.67) | TSHRCA1CA9KMT2A | |
| SCHEMBL352523 | 0.68 | TSHR (0.67) | TSHRCA1CA9KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180022864-A1 | HYDROCARBON POLYMERS HAVING TWO AZLACTONE END GROUPS | BOSTIK SA (FR) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180022864-A1 | HYDROCARBON POLYMERS HAVING TWO AZLACTONE END GROUPS | H1-2, H1-0, H1-4 | CYP2D6 1529/4885NOS3 1135/4885NOS1 796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.